NPC patients with heterozygous CT for FAS −690 were at a marginal but significantly higher risk of death compared to those with homozygous T (Hazard Ratio (HR) = 2.22, 95% CI: 0.98–5.00, Wald’s p = 0.056, Figure 2); the rest of the variants were not found to be prognostic for OS among patients with NPC (Table S1). The gene discussed is FAS; the disease is nasopharyngeal carcinoma.